Application 216755

Type
NDA
Sponsor
SAPTALIS PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LIKMEZMETRONIDAZOLESUSPENSION;ORAL500MG/5MLYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81418SUPPL 2025-03-04
81417SUPPL 2025-03-04
79014SUPPL 2024-07-09
79000SUPPL 2024-07-09
78468SUPPL 2024-05-15
78467SUPPL 2024-05-15
77189ORIG 2024-01-04
75553ORIG 2023-10-03
75558ORIG 2023-09-25